The following tests are performed on all processed cord blood units:
In December 2017, Cells for Life joined the international group of cord blood companies that comprises Cell Care in Australia and Insception Lifebank in Canada. We are processing ALL Cells for Life clients’ samples centrally at the Mississauga facility since March 2018. There is no impact on stored cord blood and tissue samples prior to the partnership. They continue to be stored at Core Cryolab to the same high quality standards.
There is no evidence that COVID-19 can be transmitted through cord blood, nor is there evidence of intrauterine vertical transmission from the mother. Since cord blood collections require thorough screening of the mother (including medical history), the chance of any transmission via cord blood is considered extremely low to non-existent.
(Source:Qiao J et al (The Lancet 395); Chen H et al (The Lancet 395); MedPage ed. Feb 12
Blood cells lack the binding sites required by the coronavirus to bind and replicate. The virus is focused on attacking the respiratory and digestive systems. Like the SARS virus, COVID-19 must enter a cell before it can start replicating. Access points for COVID-19 are indeed expressed almost all over the human body, but at high levels in the lungs and intestines, and in the oral and nasal mucosa and tongue.
Insception is not currently testing blood samples for COVID-19. Our Medical Questionnaire, completed by mothers prior to cord blood collection is being updated to request information related to the infection, including recent travel patterns and potential close contact with someone diagnosed with COVID-19. The responses will determine the requirement for follow
NB: Blood cells (maternal, umbilical) lack the binding sites required by the coronavirus to bind and replicate.
While the COVID-19 situation continues to evolve, we are doing everything possible to maintain business as usual. If you have further questions, do not hesitate to contact our Client Services team 1-866-606-2790.